Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
StockStory.org on MSN
Life sciences tools & services stocks Q1 results: Benchmarking 10x Genomics (NASDAQ:TXG)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...
According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...
StockStory.org on MSN
1 high-flying stock with solid fundamentals and 2 we find risky
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...
Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of ...
Scientists have uncovered a surprising twist in how cells behave when division goes wrong. Sometimes a cell successfully copies its DNA but fails to split into two, leaving it with double the genetic ...
AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results